DJIA 15,834.88 -370.09 -2.28%
NASDAQ 4,231.42 -131.73 -3.02%
S&P 500 1,832.08 -47.97 -2.55%
market minute promo

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP.DL)

0.00 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NPSP.DL $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS $0.00




Drug Makers

NPS Pharmaceuticals, Inc. (NPSP.DL) Description

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins. Website:

News & Commentary Rss Feed

Is it Time for this Biotech to Change Management?

With Aegerion Pharmaceuticals down 500% from its all-time high, the current CEO's tenure is trying investors' patience.

3 Niche ETFs Breaking Out

Will NPS Pharmaceuticals (NPSP) Miss on Earnings in Q4? - Analyst Blog

Shire Misses on Q4 Earnings, Revenues Beat; Shares Rise - Analyst Blog

Today's Market: Earnings Moving These Stocks, M&A In Pharma And Big Management Shakeups

Why NPS Pharmaceuticals, Inc. Shares Soared 28% in January

NPS Pharmaceuticals' stock lifts off in January after a double-dose of good news.

Wedbush Weighs in on Medivation Following Phase II TERRAIN Study Results

Shire's Vyvanse Label Expanded for Binge-Eating Disorder - Analyst Blog

NPS Pharmaceuticals' Natpara Approved with Boxed Warning - Analyst Blog

Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead

3 Motley Fool contributors offer up suggestions on what they believe Pfizer should acquire.

See More NPSP.DL News...

NPSP.DL's Top Competitors

NPSP.DL $0.00 (0.00%)
Current stock: NPSP.DL
AMGN $140.98 (-2.80%)
Current stock: AMGN
GILD $84.75 (-0.46%)
Current stock: GILD
BIIB $248.73 (-5.73%)
Current stock: BIIB